162 related articles for article (PubMed ID: 32302969)
21. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY
J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309
[TBL] [Abstract][Full Text] [Related]
22. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
23. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
[TBL] [Abstract][Full Text] [Related]
24. Development of Flow Cytometric Assay for Detecting Papillary Thyroid Carcinoma Related hsa-miR-146b-5p through Toehold-Mediated Strand Displacement Reaction on Magnetic Beads.
Wu Y; Gao J; Wei J; Zhou J; Meng X; Wang Z
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804111
[TBL] [Abstract][Full Text] [Related]
25. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
Guo K; Wang J; Shu L; Zhou G
Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
[TBL] [Abstract][Full Text] [Related]
26. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
28. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
29. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
30. Clinical Impact of Androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid Cancer Aggressiveness.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
J Clin Endocrinol Metab; 2023 Oct; 108(11):2852-2861. PubMed ID: 37220080
[TBL] [Abstract][Full Text] [Related]
31. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
32. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
33. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
34. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
Qiu Z; Li H; Wang J; Sun C
Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p.
Feng X; Dong X; Wu D; Zhao H; Xu C; Li H
Histol Histopathol; 2020 Feb; 35(2):217-224. PubMed ID: 31355416
[TBL] [Abstract][Full Text] [Related]
39. MiR-204-5p-targeted AP1S2 is necessary for papillary thyroid carcinoma.
Gu Y; Zhang X; Li Y; Shi J; Cui H; Ren Y; Liu S; Qiao Y; Cheng Y; Liu Y
Mol Cell Endocrinol; 2023 Aug; 574():111993. PubMed ID: 37328093
[TBL] [Abstract][Full Text] [Related]
40. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
